CSS
ACHN

Cubist Systematic Strategies’s Achillion Pharmaceuticals ACHN Stock Holding History

Cubist Systematic Strategies’s Portfolio ACHN Stock Details ACHN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-13,200
Closed -$48K – 2646
2019
Q3 		$48K Buy
+13,200
New +$50.9K ﹤0.01% 2051
2019
Q2 		– Sell
-19,998
Closed -$59K – 2677
2019
Q1 		$59K Sell
19,998
-68,997
-78% -$170K ﹤0.01% 2079
2018
Q4 		$142K Buy
88,995
+77,687
+687% +$220K 0.01% 1662
2018
Q3 		$42K Sell
11,308
-40,602
-78% -$121K ﹤0.01% 1734
2018
Q2 		$147K Buy
+51,910
New +$177K 0.01% 1447
2018
Q1 		– Sell
-17,692
Closed -$51K – 2181
2017
Q4 		$51K Buy
+17,692
New +$64.3K ﹤0.01% 1777
2016
Q4 		– Sell
-8,340
Closed -$68K – 1981
2016
Q3 		$68K Sell
8,340
-2,758
-25% -$23.5K ﹤0.01% 1536
2016
Q2 		$87K Hold
11,098
– – 0.01% 1530
2016
Q1 		$86K Hold
11,098
– – ﹤0.01% 1419
2015
Q4 		$120K Hold
11,098
– – 0.01% 1480
2015
Q3 		$77K Hold
11,098
– – ﹤0.01% 1672
2015
Q2 		$98K Sell
11,098
-54,142
-83% -$512K ﹤0.01% 1620
2015
Q1 		$643K Buy
65,240
+52,533
+413% +$656K 0.03% 789
2014
Q4 		$156K Sell
12,707
-83,185
-87% -$1.02M 0.01% 1588
2014
Q3 		$957K Buy
95,892
+68,955
+256% +$640K 0.06% 483
2014
Q2 		$204K Buy
+26,937
New +$107K 0.01% 1169

Other funds holding ACHN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
VI
Versor Investments New York $40.8M AUM 93.59% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
MCO
MAK Capital One New York $679M AUM 29.02% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Cubist Systematic Strategies's ACHN Position: Q4 2019 in Review

Cubist Systematic Strategies sold out of Achillion Pharmaceuticals (ACHN) in Q4 2019, closing a stake of 13,200 shares — an estimated $48K sold.

Cubist Systematic Strategies first reported a position in ACHN in Q2 2014 and held it in 16 quarters. The position peaked at $957K in Q3 2014. 132 funds tracked by Wall St. Rank hold ACHN as of Q4 2019.

  • Cubist Systematic Strategies reported no remaining Achillion Pharmaceuticals position as of Q4 2019 after selling out during the quarter.
  • Cubist Systematic Strategies sold 13,200 Achillion Pharmaceuticals shares in Q4 2019, an estimated $48K.
  • Cubist Systematic Strategies first reported a position in Achillion Pharmaceuticals in Q2 2014 and held it in 16 quarters.
  • Cubist Systematic Strategies's Achillion Pharmaceuticals position peaked at $957K in Q3 2014.
  • 132 funds tracked by Wall St. Rank held Achillion Pharmaceuticals as of Q4 2019.

Based on Cubist Systematic Strategies's 13F filing for Q4 2019, filed 14 Feb 2020.